🎗️ OncologyInjection (IV)
Kymriah
Tisagenlecleucel
CD19-directed CAR T-cell therapy for relapsed/refractory B-cell ALL and large B-cell lymphoma.
Form
Injection (IV)
Uses
2
Side effects
5
Category
Oncology
01
What is Kymriah used for?
- B-cell acute lymphoblastic leukemia (pediatric)
- Relapsed/refractory large B-cell lymphoma
02
Tisagenlecleucel side effects
The following side effects have been reported for Tisagenlecleucel. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Neurotoxicity
Infections
Cytopenias
Cardiac arrhythmia
03
Tisagenlecleucel warnings & precautions
- Black box: CRS and neurological toxicities. Only at certified centers
- REMS required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Kymriah in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.